Rapid determination of Epstein-Barr virus-specific CD8+ T-cell frequencies by flow cytometry

Blood

Volumn 94, Issue 9, 1999, Pages 3094-3100

  Kuzushima, Kiyotaka ^a   Hoshino, Yo ^b   Fujii, Ken ^b   Yokoyama, Naoaki ^b   Fujita, Masatoshi ^b   Kiyono, Tohru ^b   Kimura, Hiroshi ^b   Morishima, Tsuneo ^b   Morishima, Yasuo ^b   Tsurumi, Tatsuya ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANALYTIC METHOD; ANTIGEN SPECIFICITY; ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LYMPHOCYTE COUNT; LYMPHOMA; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

EID: 0033229704     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.9.3094     Document Type: Article

References (30)

1. Rickinson AB, Kieff E: Epstein-Barr virus, in Fields BN, Knipe DM, Howley PM (eds): Fields Virology, vol 2 (ed 3). Philadelphia, PA, Lippincott-Raven, 1996, p 2397
2. Rickinson AB, Moss DJ: Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15:405, 1997
3. Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B, Ramsay NKC, McGlave P, Filipovich AH: Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234, 1988
4. Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM: Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520, 1988
5. Smith CA, Ng CYC, Loftin SK, Heslop HE, Brenner MK, Rooney CM: Adoptive immunotherapy for Epstein-Barr virus-related lymphoma. Leuk Lymphoma 23:213, 1996
6. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, Young JW, Kernan NA, O'Reilly RJ: Infusion of donor leukocytes to Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330:1185, 1994
7. Emanuel DJ, Lucas KG, Mallory Jr GB, Edwards-Brown MK, Pollok KE, Conrad PD, Robertson KA, Smith FO: Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes. Transplantation 63:1691, 1997
8. Heslop HE, Ng CYC, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM: Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 2:551, 1996
9. Rooney CM, Smith CA, Ng CYC, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345:9, 1995
10. Rooney CM, Smith CA, Ng CYC, Loftin SK, Sixbey JW, Gan Y, Srivastava D-K, Bowman LC, Krance RA, Brenner MK, Heslop HE: Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92:1549, 1998
11. Haque T, Amlot PL, Helling N, Thomas JA, Sweny P, Rolles K, Burroughs AK, Prentice HG, Crawford DH: Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol 160:6204, 1998
12. Kuzushima K, Yamamoto M, Kimura H, Ando Y, Kudo T, Tsuge I, T Morishima T: Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Clin Exp Immunol 103:192, 1996
13. Roskrow MA, Suzuki N, Gan Y, Sixbey JW, Ng CYC, Kimgrough S, Hudson M, Brenner MK, Heslop HE, Rooney CM: Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood 91:2925, 1998
14. Bourgault I, Gomez A, Gomard E, Levy JP: Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clin Exp Immunol 84:501, 1991
15. Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ: The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood 87:2594, 1996
16. + T cell frequencies by flow cytometry. J Clin Invest 99:1739, 1997
17. Kern F, Surel IP, Brock C, Freistedt B, Radtke H, Scheffold A, Blasczyk R, Reinke P, Schneider-Mergener J, Radbruch A, Walden P, Volk H-D: T-cell epitope mapping by flow cytometry. Nat Med 4:975, 1998
18. Fabio SD, Mbawuike IN, Kiyono H, Fujihashi K, Couch RB, McGhee JR: Quantitation of human influenza virus-specific cytotoxic T lymphocytes: Correlation of cytotoxicity and increased numbers of IFNγ producing CD8+ T cells. Int Immunol 6:11, 1994
19. Herr W, Schneider J, Lohse AW, zum Buschenfelde K-HM, Wolfel T: Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor α in response to HLA-A2.1-binding melanoma and viral peptide antigens. J Immunol Methods 191:131, 1996
20. Picker U, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR, Maino VC: Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86:1408, 1995
21. + T-cell response to Epstein-Barr virus (EBV): Implications for the pathogenesis of EBV-associated lymphoproliferative disorders. Blood 91:3875, 1998
22. Harada Y, Watanabe S, Tssel H, Arai K: Factors affecting the cytokine production of human T cells stimulated by different modes of activation. J Allergy Clin Immunol 98:161, 1996
23. Steven NM, Leese AM, Annels NE, Lee SP, Rickinson AB: Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J Exp Med 184:1801, 1996
24. Carmichael A, Jin X, Sissons P, Borysiewicz L: Quantitative analysis of the human immunodeficiency virus type I (HIV1)-specific cytotoxic T lymphocyte response at different stages of HIV1 infection: Differential CTL responses to HIV1 and Epstein-Barr virus in late disease. J Exp Med 177:249, 1993
25. Hill AB, Lee SP, Haurum JS, Murray N, Yao Q-Y, Rowe M, Signoret N, Rickinson AB, McMichael AJ: Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV) nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid cell lines against which they were raised. J Exp Med 181:2221, 1995
26. Tan LC, Gudgeon N, Annels NE, Hansasuta P, O'Callaghan CA, Rowland-Jones S, McMichael AJ, Rickinson AB, Callan MF: A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol 162:1827, 1999
27. Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O'Callaghan CA, Steven N, McMichael AJ, Rickinson AB: Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 187:1395, 1998
28. Heslop HE, Li C, Krance RA, Loftin SK, Rooncy CM: Epstein-Barr infection after bone marrow transplantation. Blood 83:1706, 1994
29. Rees L, Thomas A, Amlot PL: Disappearance of Epstein-Barr virus-positive post-transplant plasmacytoma with reduction of immunosuppression. Lancet 352:789, 1998
30. Lucas KG, Burton RL, Zimmerman SE, Wang J, Cornetta KG, Robertson KA, Lee CH, Emanuel DJ: Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 91:3654, 1998